Fidelity Investments’s Impact BioMedical IBO Stock Holding History
Bought
Maintained
Sold
Other funds holding IBO
Fidelity Investments's IBO Position: Q2 2026 in Review
Fidelity Investments increased its Impact BioMedical (IBO) stake by 0.69% in Q2 2026, buying an estimated $1 and bringing the position to 292 shares worth $134. The position accounts for ﹤0.01% of the portfolio, ranked #5388.
Fidelity Investments first reported a position in IBO in Q2 2025 and has held it in 4 quarters since. The position peaked at $174 in Q1 2026. 22 funds tracked by Wall St. Rank hold IBO as of Q2 2026.
- Fidelity Investments held 292 shares of Impact BioMedical worth $134 as of Q2 2026.
- Fidelity Investments bought 2 Impact BioMedical shares in Q2 2026, an estimated $1.
- Impact BioMedical made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #5388 holding.
- Fidelity Investments first reported a position in Impact BioMedical in Q2 2025 and has held it in 4 quarters since.
- Fidelity Investments's Impact BioMedical position peaked at $174 in Q1 2026.
- 22 funds tracked by Wall St. Rank held Impact BioMedical as of Q2 2026.
Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.